GB2141025B - Compositions for percutaneous administration - Google Patents

Compositions for percutaneous administration

Info

Publication number: GB2141025B
Authority: GB; United Kingdom
Prior art keywords: compositions; percutaneous administration; percutaneous; administration
Prior art date: 1983-05-20
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired

Application number

GB08412569A

Other versions

GB8412569D0 (en

GB2141025A (en

Inventor

Jourge Heller

Wilfred A Skinner

Kenichiro Saito

Susumu Satoh

Yumiko Takakura

Yoshiaki Itoh

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Nitto Denko Corp

Original Assignee

Nitto Electric Industrial Co Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1983-05-20

Filing date

1984-05-17

Publication date

1986-09-17

1984-05-17 Application filed by Nitto Electric Industrial Co Ltd filed Critical Nitto Electric Industrial Co Ltd

1984-06-20 Publication of GB8412569D0 publication Critical patent/GB8412569D0/en

1984-12-12 Publication of GB2141025A publication Critical patent/GB2141025A/en

1986-09-17 Application granted granted Critical

1986-09-17 Publication of GB2141025B publication Critical patent/GB2141025B/en

Status Expired legal-status Critical Current

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions

GB08412569A 1983-05-20 1984-05-17 Compositions for percutaneous administration Expired GB2141025B (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US49673283A	1983-05-20	1983-05-20

Publications (3)

Publication Number	Publication Date
GB8412569D0 GB8412569D0 (en)	1984-06-20
GB2141025A GB2141025A (en)	1984-12-12
GB2141025B true GB2141025B (en)	1986-09-17

Family

ID=23973888

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
GB08412569A Expired GB2141025B (en)	1983-05-20	1984-05-17	Compositions for percutaneous administration

Country Status (8)

Country	Link
CA (1)	CA1225594A (en)
CH (1)	CH657531A5 (en)
DE (1)	DE3418565C2 (en)
DK (1)	DK239984A (en)
FR (1)	FR2547503B1 (en)
GB (1)	GB2141025B (en)
NL (1)	NL8401422A (en)
SE (1)	SE8402561L (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4637930A (en) *	1984-02-08	1987-01-20	Yamanouchi Pharmaceutical Co, Ltd.	Transdermal formulation of nicardipine hydrochloride
JPS61280426A (en) *	1985-06-04	1986-12-11	Ikeda Mohandou:Kk	Anti-inflammatory and analgesic application agent
US4826686A (en) *	1985-12-14	1989-05-02	Boehringer Ingelheim Kg	Therapeutic system
CH666621A5 (en) *	1986-06-27	1988-08-15	Ciba Geigy Ag	TOPICALLY APPLICABLE PHARMACEUTICAL COMPOSITIONS WITH SYSTEMIC EFFECT.
US4861764A (en) *	1986-11-17	1989-08-29	Macro Chem. Corp.	Percutaneous absorption enhancers, compositions containing same and method of use
GB8718886D0 (en) *	1987-08-10	1987-09-16	Ici America Inc	Composition
CA1334646C (en) *	1988-04-08	1995-03-07	James Vanolden Peck	Transdermal penetration enhancers
JPH03236317A (en) *	1989-12-06	1991-10-22	Sansei Seiyaku Kk	Dopamine derivative-containing percutaneous
US5246949A (en) *	1989-12-06	1993-09-21	Sansho Co., Ltd.	Preparation for endermism containing dopamine derivatives
WO1994021262A1 (en) *	1993-03-17	1994-09-29	Alza Corporation	Device for the transdermal administration of alprazolam
DE4432429A1 (en) *	1994-09-12	1996-03-14	Heinz Prahm	Pharmaceutical concentrates contg. lactic acid
US5693335A (en) *	1995-06-07	1997-12-02	Cygnus, Inc.	Skin permeation enhancer composition for use with sex steroids
DE19949202A1 (en) *	1999-10-13	2001-05-03	Lohmann Therapie Syst Lts	Transdermal therapeutic system for the delivery of acetylsalicylic acid and / or salicylic acid
WO2007041314A2 (en) *	2005-09-30	2007-04-12	Tti Ellebeau, Inc.	Transdermal drug delivery systems, devices, and methods employing novel pharmaceutical vehicles
JP2009522011A (en)	2005-12-30	2009-06-11	Ｔｔｉ・エルビュー株式会社	Iontophoresis system, apparatus and method for delivering an active substance to a biological interface

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB1158283A (en) *	1965-10-21	1969-07-16	Foster Milburn Company	Composition to be Applied to Skin and Process for Preparing Same.
FR2001768A1 (en) *	1968-02-12	1969-10-03	Gillette Co	N-Alkyl-2-pyrrolidone to improve cutaneous absorption - methyl, ethyl and n-butyl pyrrolidone(s), opt. with water and/or ethanol give improved skin penetration
SE325667B (en) *	1968-03-06	1970-07-06	Medisan Ab
US3472931A (en) *	1969-01-17	1969-10-14	Foster Milburn Co	Percutaneous absorption with lower alkyl amides
GB1404583A (en) *	1971-10-08	1975-09-03	Vymatt Sa	Urea compositions and methods of preparation thereof
GB1504302A (en) *	1974-08-23	1978-03-15	Fisons Ltd	Sedative method and composition
US3957994A (en) *	1974-12-19	1976-05-18	Nelson Research & Development Company	Topical anti-inflammatory composition and method of use
US3932653A (en) *	1974-12-19	1976-01-13	Nelson Research & Development Co.	Composition and method for topical administration of griseofulvin
US4017641A (en) *	1975-01-31	1977-04-12	The Procter & Gamble Company	Skin moisturizing compositions containing 2-pyrrolidinone
GB1538903A (en) *	1975-04-11	1979-01-24	Nelson Res & Dev	Carrier for a topically applied physiologically active agent or cosmetic agent
US4038417A (en) *	1975-06-19	1977-07-26	Nelson Research & Development Company	Method for treatment of psoriasis
US4316893A (en) *	1975-06-19	1982-02-23	Nelson Research & Development Co.	Vehicle composition containing 1-substituted azacycloalkan-2-ones
CA1165240A (en) *	1980-07-09	1984-04-10	The Procter & Gamble Company	Penetrating topical pharmaceutical compositions
FR2502951B1 (en) *	1981-04-06	1985-12-06	Sandoz Sa	TOPICAL PHARMACEUTICAL COMPOSITIONS IN THE FORM OF A MICRO-EMULSION

1984
- 1984-04-25 CA CA000452790A patent/CA1225594A/en not_active Expired
- 1984-05-04 NL NL8401422A patent/NL8401422A/en not_active Application Discontinuation
- 1984-05-11 SE SE8402561A patent/SE8402561L/en not_active Application Discontinuation
- 1984-05-15 DK DK239984A patent/DK239984A/en not_active Application Discontinuation
- 1984-05-17 GB GB08412569A patent/GB2141025B/en not_active Expired
- 1984-05-18 DE DE19843418565 patent/DE3418565C2/en not_active Expired
- 1984-05-18 CH CH245984A patent/CH657531A5/en not_active IP Right Cessation
- 1984-05-18 FR FR8407796A patent/FR2547503B1/en not_active Expired

Also Published As

Publication number	Publication date
CA1225594A (en)	1987-08-18
DE3418565C2 (en)	1992-05-27
GB8412569D0 (en)	1984-06-20
NL8401422A (en)	1984-12-17
SE8402561D0 (en)	1984-05-11
CH657531A5 (en)	1986-09-15
SE8402561L (en)	1984-11-21
FR2547503B1 (en)	1987-11-20
DK239984D0 (en)	1984-05-15
DE3418565A1 (en)	1984-11-22
GB2141025A (en)	1984-12-12
FR2547503A1 (en)	1984-12-21
DK239984A (en)	1984-11-21

Legal Events

Date	Code	Title	Description
1998-01-07	PCNP	Patent ceased through non-payment of renewal fee	Effective date: 19970517

Publication	Publication Date	Title
GB2142237B (en)	1987-09-23	Pharmaceutical compositions for percutaneous administration
GB2136807B (en)	1987-04-23	Pharmaceutical compositions
GB8423339D0 (en)	1984-10-17	Pharmaceutical compositions
GB8403668D0 (en)	1984-03-14	Pharmaceutical compositions
DE3467703D1 (en)	1988-01-07	Pharmaceutical compositions
GB8313217D0 (en)	1983-06-22	Pharmaceutical compositions
GB8325494D0 (en)	1983-10-26	Pharmaceutical compositions
GB8308126D0 (en)	1983-05-05	Pharmaceutical compositions
GB8325496D0 (en)	1983-10-26	Pharmaceutical compositions
GB8329043D0 (en)	1983-11-30	Pharmaceutical compositions
GB2136806B (en)	1987-04-15	Pharmaceutical compositions
DE3570598D1 (en)	1989-07-06	Composition for percutaneous administration
GB2141025B (en)	1986-09-17	Compositions for percutaneous administration
GB8414458D0 (en)	1984-07-11	Pharmaceutical compositions
CY1503A (en)	1990-08-03	Pharmaceutical compositions
GB8323553D0 (en)	1983-10-05	Pharmaceutical compositions
GB8406132D0 (en)	1984-04-11	Pharmaceutical compositions
GB8323624D0 (en)	1983-10-05	Medicinal compositions
GB2142238B (en)	1987-04-15	Pharmaceutical compositions for percutaneous administration
GB8300767D0 (en)	1983-02-16	Pharmaceutical compositions
GB8305697D0 (en)	1983-04-07	Pharmaceutical compositions
GB8425250D0 (en)	1984-11-14	Pharmaceutical compositions
GB2150435B (en)	1986-10-15	Pharmaceutical compositions
GB8331776D0 (en)	1984-01-04	Pharmaceutical compositions
GB8301718D0 (en)	1983-02-23	Pharmaceutical compositions